** Brokerage Morgan Stanley starts coverage on hospital operator Tenet Healthcare THC.N with "overweight" rating and $165 PT
** New PT represents 26.2% upside to the stock's last close
** Brokerage says significant changes in business model and balance sheet not yet reflected in THC's stock price
** Brokerage believes co is well-positioned to benefit from the shift towards outpatient care as outpatient visits have grown ~30% from 2000 to 2022, driven by technological enhancements, reimbursement changes and consumer preferences
** Notes THC's key growth areas include orthopedics, urology, cardiology, GI and cancer
** Including session moves, THC stock up 4.5% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.